Skip to main content

PHASE 3, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED

Clinical Trial Grant
Duke Scholars

Administered By

Obstetrics and Gynecology, Maternal Fetal Medicine

Awarded By

Pfizer, Inc.

Start Date

June 8, 2020

End Date

April 16, 2024
 

Administered By

Obstetrics and Gynecology, Maternal Fetal Medicine

Awarded By

Pfizer, Inc.

Start Date

June 8, 2020

End Date

April 16, 2024